- NEW Products
- DHEA Series
- Nandrolone Series
- Testosterone series
- Boldenone Series
- Drostanolone Series
- Trenbolone Series
- For Bodybuilding
- For Weight Loss
- For Cosmetic
- For Sexual Health
- T/T, west union, money gram,paypal
- within 3-5 working days
- 1kg/bag or as required
- EP 6/EP 8
Cyproterone acetate (abbreviated as CPA), also sold under brand names such as Androcur among others, is a synthetic steroidal antiandrogen, progestin, and antigonadotropin. It is primarily used in the treatment of androgen-related conditions by virtue of its ability to suppress androgenic activity in the body, an effect which it mediates by preventing endogenous androgens from interacting with the androgen receptor and by suppressing androgen biosynthesis. CPA is also used for its progestogenic effects, for instance, as a component of some combined oral contraceptive pills in combination with ethinyl estradiol (EE), such as in Diane-35 among others.
NITO Safe Delivery
---- SAFTY COMES FIRST !
Considering steroids are very special in some countries, NITO will supply professional suggestion for package+label+documents+transport mode, to ensure goods arrive safely and smoothly without and trouble.
Product name: Cyproterone Acetate
English Name: 1,2-alpha-methylene-6-chloro-delta-(sup4,6)-pregnadiene-17-alpha-ol-3,20-dio
Product Specification / Models
Packing: 1kg/bag or as required.
Storage: Store in cool and dry area and keep away from direct sunlight.
Shelf life: 2 years, if keep in formal storage condition.
CPA has been in use as an antiandrogen since 1964, and was the first antiandrogen introduced for clinical use. It is used widely throughout Europe, and is also used in Canada, Mexico, and other countries. It is not FDA-approved for use in the United States, due to concerns about hepatotoxicity; medroxyprogesterone acetate has been used in the United States instead. CPA has been approved for the treatment of prostate cancer, precocious puberty, androgen-related dermatological conditions such as acne, seborrhea, hirsutism, and androgenic alopecia, and to reduce sex drive in sex offenders. Combination formulations of CPA with EE, a formulation sometimes referred to as co-cyprindiol, have been available as contraceptives since 1997.
Other uses of CPA include the treatment of benign prostatic hyperplasia, priapism, hypersexuality, paraphilias, hot flashes, and hyperandrogenism in women. In addition, with the exception of the United States, where it is not available and spironolactone, a diuretic with antiandrogen properties, is generally employed instead, CPA is widely used as a component of hormone replacement therapy (HRT) for transgender women.
In the treatment of acne in women, a formulation of daily CPA in combination with EE has been found to result in overall improvement in 75-90% of people, with responses approaching 100% improvement.
CPA may be effective in the treatment of obsessive-compulsive disorder (OCD). In very limited clinical research, it has been reported to be "considerably" effective in the treatment of OCD in women.
Chlormadinone Acetate 302-22-7
Cinnamic Acid 621-82-9
Clobetasol Propionate 25122-46-7
Clostebol Acetate 855-19-6
Cortisone Acetate 1950/4/4
Clomiphene Citrate 50-41-9
Cyproterone Acetate 427-51-0
Creatine Phosphate Disodium 922-32-7